Quick Order Cart

Cat. No. ARG42600

CAT Knockout jurkat Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Blood (peripheral blood)

  • Disease:

    Acute lymphoblastic leukemia (ALL)

The CAT Knockout Jurkat Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population targeting the CAT gene in Jurkat T lymphocytes, creating a loss-of-function model for catalase. Catalase detoxifies hydrogen peroxide, maintaining redox homeostasis, and its activity is regulated by transcription factors such as Nrf2 and FoxO3a, while influencing downstream NF-??B and MAPK signaling. This model enables detailed studies of oxidative stress in T-cell biology, including activation, apoptosis, and signaling. It is ideal for antioxidant screening, ROS measurement with DCFDA or MitoSOX, and transcriptomic or proteomic analyses of redox-sensitive pathways.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Jurkat

    Cell Type

    T cell line

    Sex of Donor

    Male

    Age

    14 years

    Derived From Site

    In situ; Peripheral blood

    Gene Name

    CAT

    Gene Identifier

    NCBI Gene ID 847

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The CAT Knockout Jurkat Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population that disrupts the CAT gene in the Jurkat human T lymphocyte cell line. This loss-of-function model enables systematic investigation of catalase-dependent redox regulation in a well-characterized T-cell background. The polyclonal population preserves the heterogeneity inherent to CRISPR/Cas9-mediated gene disruption, providing a physiologically relevant system for studying oxidative stress responses without clonal selection artifacts.

Jurkat cells are an immortalized human T lymphocyte line originally derived from a 14-year-old male with acute T-cell leukemia. They retain key T-cell markers, including CD3, CD4, and the IL-2 receptor, and secrete IL-2 upon stimulation. This cell line is extensively employed in research on T-cell signaling, HIV infection, and leukemia biology, making it an ideal host for dissecting the role of catalase in immune cell redox homeostasis and transformation.

Catalase, encoded by the CAT gene, is the primary enzyme responsible for decomposing hydrogen peroxide into water and oxygen, thereby protecting cells from oxidative damage. Its expression is transcriptionally regulated by factors such as FoxO3a, NFE2L2 (Nrf2), and AP-1, which respond to stimuli including hydrogen peroxide, UV radiation, and TNF-alpha. Catalase interacts with peroxisomal import receptor PEX5, chaperone Hsp70, and components of the NADPH oxidase complex, and it functionally cooperates with superoxide dismutase (SOD1/SOD2), glutathione peroxidase, peroxiredoxins, and the thioredoxin system. Downstream, catalase activity modulates the MAPK pathway (ERK, JNK, p38), NF-??B, p53, and BCL2 family proteins, thereby influencing cell survival and proliferation. In the knockout model, loss of catalase elevates intracellular reactive oxygen species, dysregulating these redox-sensitive signaling networks.

In Jurkat T cells, redox balance is tightly coupled to T-cell receptor signaling, cytokine production, and apoptosis thresholds. CAT knockout therefore provides a powerful tool to examine how oxidative stress impacts T-cell activation, proliferation, and death. The model is particularly relevant for studying the intersection of redox biology and immune function in contexts such as leukemia, HIV-associated oxidative stress, and T-cell-mediated inflammation. By eliminating catalase activity, researchers can dissect the contributions of hydrogen peroxide and downstream effectors to T-cell fate decisions.

This polyclonal knockout cell population is suitable for diverse experimental applications, including oxidative stress mechanism studies, antioxidant compound screening, and apoptosis sensitivity assays following hydrogen peroxide challenge. Standard readouts include ROS detection via DCFDA or MitoSOX fluorescence, flow cytometric analysis of T-cell activation markers CD69 and CD25, Western blotting for catalase and pathway components, RT-qPCR for CAT mRNA, RNA-seq transcriptome profiling, and phospho-ERK/phospho-p38/NF-??B luciferase reporter assays. The model supports comprehensive investigations into redox signaling and its pathological consequences in T cells. For further technical information or ordering inquiries, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)